Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSchroder Real Regulatory News (SREI)

Share Price Information for Schroder Real (SREI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 43.20
Bid: 42.70
Ask: 43.00
Change: 0.00 (0.00%)
Spread: 0.30 (0.703%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 43.20
SREI Live PriceLast checked at -
Schroder Real Estate is an Investment Trust

To provide the shareholders with an attractive level of income, together with the potential for income and capital growth, from investing in a diversified portfolio of UK commercial real estate.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Re-financing to Reduce Debt Cost and Extend Duration

4 Jul 2018 07:00

Schroder Real Estate Investment Trust Ltd - Re-financing to Reduce Debt Cost and Extend Duration

Schroder Real Estate Investment Trust Ltd - Re-financing to Reduce Debt Cost and Extend Duration

PR Newswire

London, July 3

04 July 2018

Schroder Real Estate Investment Trust Limited("SREIT"/ the "Company" / "Group")

RE-FINANCING COMPLETED TO REDUCE DEBT COST AND EXTEND DURATION

Schroder Real Estate Investment Trust, the actively managed UK-focused REIT, announces that it has completed two refinancings in respect of its £129.6 million term loan with Canada Life and its £20.5 million revolving credit facility (“RCF”) with Royal Bank of Scotland (‘RBS’). These initiatives reduce the Company’s interest costs and extend the overall duration of its debt facilities.

Improved terms with the refinancing and part extension of Canada Life term loan:

The refinancing is in respect of the £25.9 million portion of the loan that was due to expire in April 2023. The maturity of this portion has been extended by five years to be co-terminus with the rest of the loan, due to expire in April 2028 and fixing this interest rate for a further five years to remove the risk of rising interest rates. The fixed interest rate cost has reduced from a 4.77% to 3.09% on this portion of the loan, saving approximately £435,000 of interest per annum. The refinancing has resulted in a negotiated break cost of £2.625 million.

Extension of the revolving credit facility:

The Company has also extended its RCF with RBS and increased the available facility from £20.5 million to £32.5 million, with £20.5 million already drawn. The additional loan amount available provides the Company with greater funding flexibility, to be used for acquisitions or capital expenditure across the portfolio. The RCF is an efficient and flexible source of funding due to the low margin of 1.6% and the ability to be repaid and redrawn as often as required and substitute assets within its security pool. The existing RCF had been due to expire in July 2019, and the new five year loan has a maturity in July 2023. The Company will also extend its interest rate caps in respect of the RCF to align with the new term of the facility and mitigate the potential risk of interest rate increases.

These transactions capitalise on current low interest rates and reposition the balance sheet for a lower cost and longer term. This active management of the balance sheet results in:

Competitive financing terms that lengthen both near-term debt maturity dates by five years, and extend the average weighted debt term from 7.7 years to approximately 9 years. The overall cost of debt reduces from 4.4% to 4.0% assuming the RCF is fully drawn. Over 80 per cent. of the Company’s debt is fixed with the remainder capped. Enlarged RCF provides additional liquidity for acquisitions and capital expenditure, with the ability to efficiently de-gear following asset sales or equity issuance. The Company’s net LTV post the transactions is approximately 26% based on the 31 March 2018 valuation, within the target ratio of 25% to 35%.

The successful refinancing combined with contemplated acquisitions should allow the Board to consider the Company’s ability to progressively increase the level of dividend.

-ENDS-

For further information:

Schroder Real Estate Investment Management Limited: Duncan Owen / Nick Montgomery / Frank Sanderson020 7658 6000
Northern Trust: Fraser Hiddelston01481 745529
FTI Consulting: Dido Laurimore / Richard Gotla020 3727 1000
Date   Source Headline
13th Mar 20244:44 pmRNSHolding(s) in Company
8th Mar 20245:01 pmRNSHolding(s) in Company
6th Mar 20245:46 pmRNSHolding(s) in Company
6th Mar 20245:42 pmRNSHolding(s) in Company
29th Feb 20242:13 pmRNSInvestor Presentation
27th Feb 20247:00 amRNSNAV and Dividend for Quarter to 31 December 2023
26th Jan 20245:02 pmRNSQuotedData's Weekly News & Interview
26th Jan 20244:23 pmRNSQuotedData's Weekly News & Interview
15th Dec 20231:03 pmRNSResult of EGM
11th Dec 202312:13 pmRNSHolding(s) in Company
21st Nov 20238:35 amRNSWebinar details
21st Nov 20237:01 amRNSDividend Announcement for the Quarter to 30 Sep 23
21st Nov 20237:00 amRNSPublication of circular and notice of EGM
21st Nov 20237:00 amRNSInterim Results for the period ended 30 Sept 2023
1st Nov 20237:00 amRNSNon-Executive Director Change
18th Oct 20234:08 pmRNSInvestor Presentation
27th Sep 20234:54 pmRNSResult of AGM
26th Sep 20234:47 pmRNSHolding(s) in Company
22nd Sep 20237:00 amRNSNotice of Results
8th Sep 202311:21 amRNSHolding(s) in Company
27th Jul 20232:43 pmRNSAnnual Report for year ended 31 March 2023
27th Jul 20232:11 pmRNSInvestor Presentation
27th Jul 20237:00 amRNSNAV and Dividend for the Quarter to 30 June 2023
8th Jun 20236:26 pmRNSDividend PID Status
8th Jun 202311:29 amRNSHolding(s) in Company
8th Jun 20237:01 amRNSDividend Declaration
8th Jun 20237:00 amRNSFull Year Results for the year ended 31 March 2023
2nd Jun 202311:18 amRNSInvestor Presentation
2nd May 20239:00 amRNSNotice of Full Year Results
20th Apr 202310:12 amRNSDirector Declaration
10th Mar 20232:12 pmRNSDirector/PDMR Shareholding
1st Mar 20234:34 pmRNSHolding(s) in Company
3rd Feb 20234:13 pmRNSInvestor Presentation
3rd Feb 20237:00 amRNSNAV and Dividend for the quarter to 30 Dec 2022
12th Dec 20227:00 amRNSKepler Trust Intelligence: New Research
1st Dec 20224:41 pmRNSHolding(s) in Company
16th Nov 20227:01 amRNSDividend Declaration
16th Nov 20227:01 amRNSDirectorate Change
16th Nov 20227:00 amRNSInterim results for the period ended 30 September
19th Oct 20227:00 amRNSInvestor Presentation
12th Oct 20227:00 amRNSNotice of Half Year Results
30th Sep 20224:53 pmRNSTotal Voting Rights
21st Sep 20224:10 pmRNSResult of AGM
15th Sep 20225:34 pmRNSTransaction in Own Shares
14th Sep 20225:18 pmRNSTransaction in Own Shares
13th Sep 20225:21 pmRNSTransaction in Own Shares
12th Sep 20225:33 pmRNSTransaction in Own Shares
9th Sep 20225:33 pmRNSTransaction in Own Shares
8th Sep 20225:29 pmRNSTransaction in Own Shares
7th Sep 20226:00 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.